Onconetix Announces Financing Through a $2.0 Million Private Placement of Series C Preferred Stock and Warrants, Establishes a $25 Million Equity Line of Credit

2 weeks ago

CINCINATTI, Oh., Oct. 03, 2024 ( GLOBE NEWSWIRE ) -- Onconetix, Inc. ( Nasdaq: ONCO ) ( "Onconetix" or "the Company" ) ( formerly Blue Water Biotech, Inc. ( BWV ) ) , a cancer diagnostics company focused on the research, development and commercialization of innovative solutions for oncology, ...

Ticker	Sentiment	Impact
ONCO	Somewhat Bullish	29 %